BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12083632)

  • 21. Elimination of the differential chemoresistance between the murine B-cell lymphoma LY-ar and LY-as cell lines after arsenic (As2O3) exposure via the overexpression of gsto1 (p28).
    Giri U; Terry NH; Kala SV; Lieberman MW; Story MD
    Cancer Chemother Pharmacol; 2005 Jun; 55(6):511-21. PubMed ID: 15761769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell cycle arrest and apoptotic cell death in cultured human gastric carcinoma cells mediated by arsenic trioxide.
    Shao QS; Ye ZY; Ling ZQ; Ke JJ
    World J Gastroenterol; 2005 Jun; 11(22):3451-6. PubMed ID: 15948253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Essential role of cell cycle regulatory genes p21 and p27 expression in inhibition of breast cancer cells by arsenic trioxide.
    Wang X; Gao P; Long M; Lin F; Wei JX; Ren JH; Yan L; He T; Han Y; Zhang HZ
    Med Oncol; 2011 Dec; 28(4):1225-54. PubMed ID: 20458559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Primary research on arsenic trioxide inhibiting human breast cancer cells growth and its mechanisms].
    Wei L; Wang XW; Zuo WS; Song XR
    Zhonghua Yi Xue Za Zhi; 2005 May; 85(17):1209-13. PubMed ID: 16029599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro exposure of acute promyelocytic leukemia cells to arsenic trioxide (As2O3) induces the solitary expression of CD66c (NCA-50/90), a member of the CEA family.
    Di Noto R; Boccuni P; Costantini S; Dello Russo A; Lo Pardo C; Copia C; Annunziata M; Cimino R; Ferrara F; Del Vecchio L
    Tissue Antigens; 1999 Dec; 54(6):597-602. PubMed ID: 10674975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autophagy plays a pro-apoptotic role in arsenic trioxide-induced cell death of liver cancer.
    Deng ZT; Liang SF; Huang GK; Wang YQ; Tu XY; Zhang YN; Li S; Liu T; Cheng BB
    J Integr Med; 2024 May; 22(3):295-302. PubMed ID: 38599914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Demethylation and alterations in the expression level of the cell cycle-related genes as possible mechanisms in arsenic trioxide-induced cell cycle arrest in human breast cancer cells.
    Moghaddaskho F; Eyvani H; Ghadami M; Tavakkoly-Bazzaz J; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
    Tumour Biol; 2017 Feb; 39(2):1010428317692255. PubMed ID: 28218039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphoinositide 3-kinase/Akt inhibition increases arsenic trioxide-induced apoptosis of acute promyelocytic and T-cell leukaemias.
    Tabellini G; Tazzari PL; Bortul R; Evangelisti C; Billi AM; Grafone T; Martinelli G; Baccarani M; Martelli AM
    Br J Haematol; 2005 Sep; 130(5):716-25. PubMed ID: 16115127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arsenic Trioxide Promotes Paclitaxel Cytotoxicity in Resistant Breast Cancer Cells.
    Bakhshaiesh TO; Armat M; Shanehbandi D; Sharifi S; Baradaran B; Hejazi MS; Samadi N
    Asian Pac J Cancer Prev; 2015; 16(13):5191-7. PubMed ID: 26225652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apoptosis induced by arsenic trioxide in leukemia U937 cells is dependent on activation of p38, inactivation of ERK and the Ca2+-dependent production of superoxide.
    Iwama K; Nakajo S; Aiuchi T; Nakaya K
    Int J Cancer; 2001 May; 92(4):518-26. PubMed ID: 11304686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system.
    Dai J; Weinberg RS; Waxman S; Jing Y
    Blood; 1999 Jan; 93(1):268-77. PubMed ID: 9864170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arsenic trioxide and promyelocytic leukemia protein-adenovirus synergistically inhibit in vitro and in vivo growth of a hepatoma cell line.
    Cui L; Zhang S; Zhang W; Hu Z; Cao Z; Li T
    Oncol Res; 2010; 18(7):305-14. PubMed ID: 20377131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential role of caspase-3 and -9 in arsenic trioxide-mediated apoptosis in PCI-1 head and neck cancer cells.
    Seol JG; Park WH; Kim ES; Jung CW; Hyun JM; Lee YY; Kim BK
    Int J Oncol; 2001 Feb; 18(2):249-55. PubMed ID: 11172589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of apoptosis and inhibition of telomerase activity by arsenic trioxide (As2O3) in endometrial carcinoma cells.
    Zhou C; Boggess JF; Bae-Jump V; Gehrig PA
    Gynecol Oncol; 2007 Apr; 105(1):218-22. PubMed ID: 17275888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of arsenic trioxide (As2O3) on human megakaryocytic leukemia cell lines. With a comparison of its effects on other cell lineages.
    Alemany M; Levin J
    Leuk Lymphoma; 2000 Jun; 38(1-2):153-63. PubMed ID: 10811458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of As2O3 on cell cycle progression and cyclins D1 and B1 expression in two glioblastoma cell lines differing in p53 status.
    Zhao S; Tsuchida T; Kawakami K; Shi C; Kawamoto K
    Int J Oncol; 2002 Jul; 21(1):49-55. PubMed ID: 12063549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Potentiation of arsenic trioxide-induced apoptosis by retinoic acid in retinoic acid sensitive and resistant HL-60 myeloid leukemia cells].
    Huang X
    Chin Med J (Engl); 2000 Jun; 113(6):498-501. PubMed ID: 11775865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Arsenic trioxide induced cell apoptosis by mitochondria dependent pathway in KB and KBv200 cells].
    Li YF; Wang XD; Liang YJ; Chen LM; Ding Y; Huang M; Fu LW
    Ai Zheng; 2004 Jun; 23(6):631-4. PubMed ID: 15191660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Catalase activity and arsenic sensitivity in acute leukemia.
    Coe E; Schimmer AD
    Leuk Lymphoma; 2008 Oct; 49(10):1976-81. PubMed ID: 18949620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiosensitizing effects of arsenic trioxide on MCF-7 human breast cancer cells exposed to 89 strontium chloride.
    Liu H; Tao X; Ma F; Qiu J; Wu C; Wang M
    Oncol Rep; 2012 Nov; 28(5):1894-902. PubMed ID: 22922982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.